Mallinckrodt’s @Nuclear Quarterly Newsletter for September 2016

Check out Mallinkrodt’s @Nuclear Quarterly Newsletter for June 2015.  Included in this newsletter is a discussion of Mallinkrodt’s full-cost recovery implementation plan, which is necessary to ensure a long-term reliable supply of Mo-99 for the global market.

Please read our recent letter from Lantheus Medical Imaging regarding the secure and continous supply of Xenon Xe-133 Gas.

Click the below link for registration and scheduling information regarding the Eastern Great Lakes Chapter meeting being held in Buffalo, NY from May 8th – 9th, 2015.

2015 Eastern Great Lakes Chapter Society of Nuclear Medicine & Molecular Imaging’s Annual Meeting

Please see this recent email by SNMMI’s President, Gary L. Dillehay, MD, FACNM, FACR to all SNMMI members.  If interested, there is a survey at the bottom of the email regarding the status of a long-term supply of medical radioisotopes.

The recent (May 5th, 2014) SNMMI SmartBrief reported,

“Jubilant DraxImage has announced a one-time price increase for macroaggregated albumin and diethylenetriamine pentaacetate, used for ventilation/perfusion scans in the U.S. Jubilant President Martyn Coombs said the price hike was instituted to ensure long-term supply to the medical community. The company also plans to invest in manufacturing changes to avoid shortages.”  

You can read the rest of this article for free here.

Please click here to view the latest Mo-99 supply update by Mallinckrodt Pharmaceuticals.

CRS Nuclear Services receives quarterly newsletters from Mallinckrodt Pharmaceuticals.  Each quarterly issue aims to provide insights on emerging industry trends, helpful best practices from Mallinckrodt’s team and profiles of industry peers.  Here is the most recent edition of the @nuclear newsletter.  

SNMMI President, Gary Dillehay, MD, recently wrote a letter to all of SNMMI membership regarding the MAA price increase.  This letter can be found here.